Technical Analysis for PASG - Passage Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
22.725 | -3.99% | -0.95 |
PASG closed down 3.19 percent on Thursday, July 9, 2020, on 89 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Historical PASG trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | -3.99% | |
| MACD Bearish Centerline Cross | Bearish | -3.99% | |
| Wide Bands | Range Expansion | -3.99% | |
| Down 3 Days in a Row | Weakness | -3.99% | |
| Down 4 Days in a Row | Weakness | -3.99% | |
| Oversold Stochastic | Weakness | -3.99% | |
| 50 DMA Support | Bullish | -7.06% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -7.06% | |
| Outside Day | Range Expansion | -7.06% | |
| Wide Bands | Range Expansion | -7.06% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/11/2020
- Sector: Healthcare
- Industry: Biotechnology
Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
Medicine Health Organ Systems Rare Diseases Lipid Storage Disorders Aditya Kohli Rare Tadataka Yamada
Medicine Health Organ Systems Rare Diseases Lipid Storage Disorders Aditya Kohli Rare Tadataka Yamada
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 38.23 |
| 52 Week Low | 8.09 |
| Average Volume | 236,103 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 24.49 |
| 20-Day Moving Average | 28.50 |
| 10-Day Moving Average | 26.88 |
| Average True Range | 2.91 |
| ADX | 19.13 |
| +DI | 15.87 |
| -DI | 21.27 |
| Chandelier Exit (Long, 3 ATRs ) | 29.49 |
| Chandelier Exit (Short, 3 ATRs ) | 31.09 |
| Upper Bollinger Band | 36.71 |
| Lower Bollinger Band | 20.28 |
| Percent B (%b) | 0.21 |
| BandWidth | 57.66 |
| MACD Line | -0.04 |
| MACD Signal Line | 1.08 |
| MACD Histogram | -1.1211 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 26.79 | ||||
| Resistance 3 (R3) | 26.96 | 26.09 | 26.27 | ||
| Resistance 2 (R2) | 26.09 | 25.30 | 26.01 | 26.10 | |
| Resistance 1 (R1) | 24.88 | 24.80 | 24.45 | 24.71 | 25.92 |
| Pivot Point | 24.01 | 24.01 | 23.79 | 23.93 | 24.01 |
| Support 1 (S1) | 22.80 | 23.22 | 22.37 | 22.63 | 21.42 |
| Support 2 (S2) | 21.93 | 22.72 | 21.85 | 21.24 | |
| Support 3 (S3) | 20.72 | 21.93 | 21.07 | ||
| Support 4 (S4) | 20.55 |
